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ABSTRACT.
Purpose: Photoscreening assesses risk factors for amblyopia, as an alternative
to measurement of visual acuity (VA) to detect amblyopia, on the premise that its
early correction could prevent development of amblyopia. We studied imple-
mentations of Plusoptix photoscreening in existing population-based screening in
Flanders and Iran.
Methods: In Flanders, VA is measured at age 3, 4 and 6, photoscreening was
added to existing screening at age 1 and 2.5 years in 2013. In Iran, VA is
measured at ages 3–6 years, photoscreening was added at ages 3–6 years
between 2011 and 2016. Plusoptix use was analysed in the literature for detection
of risk factors for amblyopia and amblyopia itself, for ages 0–3 and for 4–6. A
questionnaire, containing seven domains: existing vision screening, addition of
photoscreening, implementation in screening program, training, attendance,
diagnosis and treatment, and costs was distributed. In Iran, screening procedures
were observed on site.
Results: Implementation of Plusoptix photoscreening was mainly analysed from
questionnaires and interviews, its eﬀectiveness from literature data. In Flanders,
of 56 759 children photoscreened at age one (81% of children born in 2013),
9.2% had been referred, 13% of these were treated, mostly with glasses,
resulting in an increase of 4-year-old children wearing glasses from 4.7% to
6.4%. In Iran, 90% of children aged 3–6 years participated in vision screening in
2016, but only those who failed the vision test were subjected to photoscreening.
Conclusions: In Flanders, the use of Plusoptix photoscreening at ages 1 and 2.5
resulted in an increase of children wearing glasses, but it remains unknown how
many cases of amblyopia have been prevented. Studies are needed to determine
the relation between size and sort of refractive error and strabismus, and the
increased chance to develop amblyopia.
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Introduction
Amblyopia is a decrease of visual
acuity (VA) of an eye caused by not
using that eye, for instance in case of
strabismus or when the image of the
eye is out of focus in case of high
refractive error (particularly hyperme-
tropia or astigmatism), and especially if
it diﬀers between the eyes (ani-
sometropia). If a child with strabismus
ﬁxates predominantly with one eye, the
perception of the other image of the
other eye is suppressed. Amblyopia has
a prevalence of approximately 3.25%
(Groenewoud et al. 2010). Treatment is
very eﬀective if carried out in child-
hood, necessitating detection of ambly-
opia, for example by measurement of
VA, at ages 4–5 (Atkinson et al. 1996).
While strabismus may be noticed by
parents, the amblyopia due to refrac-
tive error may remain unnoticed until
much later (Sloot et al. 2015b). There
is also evidence to suggest that early
correction of hypermetropia can pre-
vent the onset of some types of stra-
bismus and that early correction of
refractive error can prevent refractive
amblyopia (Atkinson et al. 1996).
Hence, a logical step seems measure-
ment of refractive error (refraction)
and, in case of large refractive error,
prescription of glasses as early as pos-
sible, in childhood, to avoid develop-
ment of amblyopia.
No studies have been carried out yet
that determined the relation between
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the size and sort of the refractive error
or strabismus, and the increased odds
to develop amblyopia. In 2003, the
American Academy of Pediatric Oph-
thalmology and Strabismus (AAPOS)
developed criteria for referral after
photoscreening (Donahue et al. 2003,
2013). It was recommended that a child
is referred by a screener to an orthop-
tist or ophthalmologist, in case of
anisometropia > 1.5 dioptres, hyper-
metropia > 3.5 dioptres, astigma-
tism > 1.5 dioptres or in case of
astigmatism with oblique axis > 1.0
dioptres, myopia < 3.0 dioptres or
manifest strabismus (Donahue et al.
2003). In 2013, the threshold of the
AAPOS criteria was raised because too
many children were being referred. The
updated criteria for children aged 12–
30 months were as follows: astigma-
tism > 2.0 dioptres, hypermetropia >
4.5 dioptres and anisometropia > 2.0
dioptres, and for children aged 31–
48 months: astigmatism > 2.0 dioptres,
hypermetropia > 4.0 dioptres and ani-
sometropia > 2.0 dioptres (Donahue
et al. 2013).
Photoscreener devices are widely
used in several countries in the world
to detect risk factors for development
of amblyopia. All of these devices
measure the refractive power of the
eye, and, hence, can indicate if glasses
are needed, and some photoscreeners
can also detect strabismus in young
children. These devices can be used
before age 3. Measurement of VA in
children at the age of 36 months as
part of population-wide screening fails
in 16.6% of children, in addition to
15.5% of children not reaching the
threshold and, hence, cannot be done
cost-eﬀectively (Telleman et al. 2018).
The rates of failed measurement of VA
are lower when performed by experi-
enced orthoptists (Becker et al. 2002).
Visual acuity (VA) can be measured
even in younger children by preferen-
tial-looking techniques, but only with
highly trained personnel taking suﬃ-
cient time (Atkinson et al. 1983).
Photoscreeners have gained popu-
larity in the United States, where
national vision screening programs
and trained personnel have been
scarce. In the United States, several
photoscreener devices have been used,
such as the MTI photoscreener, the
West Palm Beach, the Visiscreen OSS-
c, the iScreen system, the Welch Allyn
Suresight vision screener and the
Plusoptix photoscreener (Arthur et al.
2009). All have been shown to be
eﬀective in detecting refractive errors
in young children, to varying degree.
The Plusoptix photoscreener, a Ger-
man made, handheld video-refractor,
also measures pupil size, interpupillary
distance and eye alignment. The soft-
ware algorithm derives the refractive
strength of the eye of the light crescent,
visible in the pupil when using oﬀ-axis,
infrared illumination (Sanchez et al.
2016). Diﬀerent versions of the basic
software and equipment are marketed
as screening devices, set up to report a
pass/fail criterion based on predeter-
mined settings (S04, S08, S09, S12 and
S16) for community screening by min-
imally skilled personnel, as auto-refrac-
tors (A09, A12 and A16) which assess
refractive error in ophthalmic prac-
tices, and also as specialist ‘Power-
Refractors’ sold for laboratory use
(Sanchez et al. 2016). The fundamental
beneﬁts of the Plusoptix photoscreener
device over other photoscreeners are
that it assesses both eyes simultane-
ously, thus, it can also detect strabis-
mus in most cases and it is very quick
to administer, but it also has some
drawbacks such as limited operating
range and a high ‘untestable’ rate
(Arthur et al. 2009).
Many studies on photoscreening
have been published, but none of these
describe the implementation of photo-
screening at a national scale. The
Plusoptix photoscreener has only been
incorporated into nationwide existing
screening programs in Flanders and in
Iran.
In vision screening in Flanders (Bel-
gium), visual acuity (VA) is measured
at age 3, 4 and 6 years. In 2013, the
Plusoptix photoscreener was added at
age 1 and 2.5 years for detection of
amblyopia risk factors such as refrac-
tive error and strabismus. In vision
screening in Iran, VA is measured 1–3
times between ages 3 and 6. In 2011,
the Plusoptix photoscreener was ﬁrst
added. Currently, photoscreening is
used in all of Iran at ages 3–6, but
primarily in children in whom the
measurement of VA has failed.
For this study, we performed a ﬁeld
orientation study including interviews
and on site observations in Flanders
and in Iran, to evaluate the experience
in the ﬁrst years of adding photoscreen-
ing to existing vision screening pro-
grams.
Methods
A literature search on the eﬀectiveness
and possible role of the Plusoptix
photoscreener in the detection of visual
disorders was performed based on
original papers and systematic reviews
in addition to a literature search on the
vision screening programs in Flanders,
Iran and the Netherlands. We searched
the PubMed database, Medline data-
base and Cochrane Library data on 10
October 2017. A widespread electronic
search was performed using several
keywords both individually and in
combination, such as photoscreener,
Plusoptix, power refractor, preschool
vision screening, vision screening, auto-
refraction, paediatric vision screening
and cycloplegic auto-refraction. Stud-
ies were selected by title and abstract
analysis. Studies were eligible if they
described primarily the eﬀectiveness of
the Plusoptix photoscreener in vision
screening programs and compared it to
a comparison group. Further inclusion
criteria were as follows: English lan-
guage, papers on handheld-devices
speciﬁcally the Plusoptix photo-
screener, on early detection of ambly-
opia with explanation of the referral
criteria, and on photoscreening in
healthy children only, original papers
and systematic reviews. Exclusion cri-
teria were as follows: papers on chil-
dren older than 10 years old, on
handheld-devices which did not men-
tion the Plusoptix photoscreener and
papers without a comparison group. If
the studies seemed eligible, the full text
was read.
Literature data analysis
Data from the literature were analysed
with the PICO procedure (Huang et al.
2006). The acronym PICO stands for:
Patient, Population, Problem, Inter-
vention, Comparison and Outcome.
In principle, the PICO that was
addressed was fourfold, as two age
groups and two target conditions were
evaluated.
The two Patient groups were as
follows: children aged 0–3 years and
4–6 years. This distinction in age was
made because VA can reliably be
measured from age 4 onwards.
For the Interventions, the distinction
was made between the two target
conditions: risk factors for amblyopia
and amblyopia itself.
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Comparison 1: Retinoscopy under
cycloplegia. Cycloplegic retinoscopy,
performed by orthoptists, ophthalmol-
ogists or optometrists, is the gold
standard for measurement of refractive
errors in young children. It is usually
done after administration of eye drops
that cause temporary paralysis of
accommodation: cycloplegia. This pro-
cedure cannot be used for screening of
all children in the population as it takes
a long time, is unpleasant for the child,
needs speciﬁc skills and safety measures
and would, hence, be prohibitively
expensive.
Comparison 2: Measurement of VA.
Measurement of VA at age 4–6 is the
gold standard for the diagnosis of
amblyopia, especially if performed by
trained personnel, and after exclusion
of other causes of decreased VA. The
diﬀerence between the VA in the
amblyopic eye and the VA of the better
eye should be at least two LogMAR
lines for diagnosis of amblyopia to be
made and other causes of decreased
VA like structural abnormalities of the
eyes are absent. In summary, we
deﬁned four Outcomes in the analysis,
as two age groups 0–3 and 4–6 and two
target conditions were evaluated.
Data collection
The literature search preceded the
interviews. A ﬁeld orientation study
was performed using questionnaires.
The questionnaires were distributed
among local stakeholders in vision
screening in Flanders and in Iran.
Stakeholders were subsequently inter-
viewed in person. In Iran, screening
procedures were also observed on site.
Questionnaires with seven domains
(Appendices 1 & 2) were developed by
a focus group (paediatric ophthalmol-
ogists, orthoptists and public health-
care researchers), and consists of the
following domains: (1) pre-existing
vision screening program, (2) age of
addition of photoscreening, (3) imple-
mentation in the screening program,
(4) training, (5) attendance, (6) diagno-
sis and treatment and (7) costs of vision
screening. From these data and the
literature, the current provision of
childhood screening and the types of
screening programs used were identi-
ﬁed in both countries. The question-
naires were based on the questionnaires
of the EUSCREEN Study. In this
study, data are being collected about
paediatric vision and hearing screening
programs from countries in Europe
and compared for cost-eﬀectiveness
(Sloot et al. 2015a). Interviews were
either recorded or notes were taken.
Answers were collated and cannot be
traced to named individuals. Data of
vision screening in Flanders and Iran
were collected from electronic screen-
ing records by the head of the depart-
ment of the child healthcare centres. In
Flanders, data collection was provided
from interviews and electronic screen-
ing records by the Central advisory
Doctor of the department of ‘Kind en
Gezin’ which is a governmental agency
in Brussels, coordinating screening pro-
grams in Flanders. In Iran, data col-
lection was provided from interviews
and unpublished electronic screening
records from the national Welfare
Organization in Tehran named ‘Saz-
man Behzisti Keshvar’. In Iran, all
screening programs are organized by
Welfare Organizations, which are paid
by the government.
Results
Our literature search produced 38
papers on assessment of the eﬀective-
ness of the Plusoptix photoscreening in
detecting risk factors for amblyopia: 20
papers met the inclusion criteria. We
found seven studies with the speciﬁed
sensitivity and speciﬁcity for detection
of risk factors for amblyopia in com-
parison with cycloplegic retinoscopy
and one study with speciﬁed sensitivity
and speciﬁcity for detection of ambly-
opia in comparison with measurement
of VA. A total of eight studies were
included.
As for outcome of the PICO, the two
age categories have been analysed
together, as in the process of data
analysis it turned out that several
studies included children from both
age groups (Table 1). Seven studies
examined only the detection of risk
factors for amblyopia and not the
detection of amblyopia itself. One
recent study (Van der Ploeg et al.
2017) compared screening with Plusop-
tix photoscreening with screening with
measurement of VA, at the ages of 36,
45 and 60 months. The Plusoptix pho-
toscreener does not measure VA and
therefore cannot diagnose amblyopia
per se but it does detect risk factors for
amblyopia, like refractive errors and
strabismus. Therefore, the PICO
primarily provided: outcome measures
on the parameter: detection of ambly-
opia risk factors in children aged 0–3
and 4–6 years together.
Outcome one: Detection of amblyopia risk
factors in children aged 0–3 and 4–6 years
Arnold et al. investigated the diagnos-
tic accuracy of the Plusoptix S09 pho-
toscreener for detection of refractive
error or strabismus in 108 children with
amblyopia between 9 and 146 months
old, using the AAPOS 2003 criteria.
Children were examined by the Plu-
soptix photoscreener, followed by an
ophthalmic examination consisting of
measurement of VA, eye examination
and cycloplegic refraction. Sensitivity
in children aged 4 and younger was
74%, speciﬁcity 92% and positive pre-
dictive value of 89%. In 21% of
children, examination with the Plusop-
tix photoscreener failed (Arnold &
Armitage 2014).
Ehrt et al. investigated screening for
refractive errors by the Plusoptix S04
photoscreener in 161 children between
6 and 72 months old. The criteria for
amblyogenic refractive errors were cho-
sen according to German criteria
deﬁned by Arens & Bertram in 1998:
hypermetropia ≥ 3.0 dioptres, myopia
≤2.0 dioptres, astigmatism ≥ 1.0
dioptres and anisometropia ≥ 1.0 diop-
tres. Sensitivity was 70% and speci-
ﬁcity 80%. In 15% of children, no
measurements were available (Ehrt
et al. 2007).
Huang et al. studied the perfor-
mance of the Plusoptix A12C photo-
screener in 1766 children between 3 and
4 years old using the AAPOS 2013
criteria. The outcomes of measurement
of refractive error were available in 359
children; sensitivity was 93%, speci-
ﬁcity 94% and positive predictive value
41%. Sensitivity for strabismus was
25%, speciﬁcity 99.8% and positive
predictive value 25% (Huang et al.
2017).
Paﬀ et al. evaluated the diagnostic
accuracy of the Plusoptix S08 photo-
screener for detection of strabismus
and refractive errors based on the
AAPOS 2003 criteria. Therefore, Plu-
soptix photoscreening measurements
were compared to the outcome of a
cover test to detect manifest strabismus
and cycloplegic refraction. In total, 200
children between 3 months and
11 years were included. Sensitivity for
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hypermetropia refractive error was
33.3%. for myopia 74% and for stra-
bismus 37% (Paﬀ et al. 2010).
Sanchez et al. investigated the diag-
nostic accuracy of the Plusoptix S04,
S08, S09 and A09 in early detection of
amblyopia in a review. Both manufac-
turer criteria and the AAPOS 2003
criteria were used to determine refrac-
tive error and strabismus. The Plusop-
tix photoscreener and most other
photoscreeners were reported to have
missed or underestimated the presence
of strabismus (an important amblyo-
genic risk factor) with a sensitivity of
41% (Sanchez et al. 2016).
Yann et al. studied the performance
of the Plusoptix A09 photoscreener in
detecting amblyopia risk factors com-
pared to cycloplegic retinoscopy in 178
children between 2.2 and 14.1 years old
using the AAPOS 2003 criteria. Sensi-
tivity was 94.9% and speciﬁcity 67.5%
for detection of refractive error. Sensi-
tivity for detection of strabismus was
40.7% and speciﬁcity 98.3% (Yan
et al. 2015).
The eﬀectiveness of the detection of
risk factors for amblyopia at an age
that VA can be measured has only been
examined in the study of Matta et al.
(2010). They studied the performance
of the Plusoptix S04 photoscreener for
detection of risk factors for amblyopia
in children aged 3–5 in a paediatric
ophthalmology practice using the
AAPOS 2003 criteria. In total, 153
children were included. After cyclople-
gia, 81 children were found to have risk
factors for amblyopia after Plusoptix
photoscreening, 93 children were found
to have risk factors for amblyopia.
Sensitivity after Plusoptix photoscreen-
ing was 99%, speciﬁcity 82%, the false-
positive rate 18% and the false negative
rate 1.2%. Compared to the general
population, the children included in
this study were from an orthoptic
practice, were an enriched population
with a higher prevalence of amblyopia
(Matta et al. 2010).
Outcome two: Detection of amblyopia in
children aged 0-3 and 4-6 years
Van der Ploeg et al. (2017) examined
routine vision screening taking place at
Youth Health Care Centers (YHCC) in
the Netherlands. They compared cur-
rent measurement of VA at ages 36, 45
and 60 months, the latter two, using
Landolt-C optotypes, with the Plusop-
tix S12C photoscreener using referral
based on the AAPOS 2013 criteria. In
total, 2144 children were examined
with both methods. Twenty-nine from
294 children were referred because of
abnormal VA test, against 23 from 140
children who did not meet the AAPOS
2013 criteria with the Plusoptix test.
Sensitivity for detection of amblyopia
with the Plusoptix photoscreener was
63% and speciﬁcity was 94%. Sensitiv-
ity for detection of amblyopia with the
Landolt-C was 67% and speciﬁcity was
87%. However, most children had had
one or two VA measurements before,
at 36 months or at 36 and 45 months,
and children who were being treated by
an orthoptist or wore glasses were
excluded from the study: 3% at
36 months, 9.1% at 45 months and
11.7% at 60 months, respectively.
Hence, amblyopia detection was stud-
ied in a population where most cases of
amblyopia had already been detected
and excluded from participation of the
study.
Field orientation in
Flanders
Vision screening in Flanders has been
oﬃcially regulated by the government
since 2000. In the vision screening
program, most cases of amblyopia are
detected by measurement of visual
acuity at age 3, by the Kay Crowded
Book at 3 metres, and at the ages 4 and
6 by the LogMAR Crowded Test, at
school and at Child Health Care Cen-
ters (CHCC). The vision screening is
Table 1. Sensitivity and speciﬁcity of detection of risk factors for amblyopia: refractive error and strabismus, and for detection of amblyopia itself
with the Plusoptix photoscreener (Van der Ploeg et al. 2017).
References
Age child
(months)
Plusoptix
type Target condition Comparison Sensitivity (%) Speciﬁcity (%)
Arnold et al.
(2014)
9–48 S09 Amblyopia risk factors Cycloplegic
retinoscopy
Refractive error and
strabismus
74 Refractive error and
strabismus
94
Ehrt et al. (2007) 6–72 S04 Amblyopia risk factors Cycloplegic
retinoscopy
Refractive error and
strabismus
70 Refractive error and
strabismus
80
Huang et al.
(2017)
36–48 A12C Amblyopia risk factors Cycloplegic
retinoscopy
Refractive error 93 Refractive error 94
Strabismus 25 Strabismus 99.8
Matta et al.
(2010)
36–60 S04 Amblyopia risk factors Cycloplegic
retinoscopy
Refractive error 99 Refractive error 82
Paﬀ et al. (2010) 3–132 S08 Amblyopia risk factors Cycloplegic
retinoscopy
Hypermetropia 33 Hypermetropia 98
Myopia 74 Myopia 98
Astigmatism 90 Astigmatism 78
Strabismus 37
Van der Ploeg
et al. (2017)
36 S12C Amblyopia risk factors
& amblyopia
APK - -
45 S12C Landolt-C Landolt-C 67 Landolt-C 87
60 S12C Landolt-C Plusoptix 63 Plusoptix 94
Sanchez et al.
(2016)
- S04, S08
S09, A09
Amblyopia risk factors Cycloplegic
retinoscopy
Hypermetropia 44 Hypermetropia 98
Myopia 86 Myopia 95
Astigmatism - -
Strabismus 41 Strabismus 98
Yan et al. (2015) 26–169 A09 Amblyopia risk factors Cycloplegic
retinoscopy
Refractive error 95 Refractive error 7.5
Strabismus 41 Strabismus 8.3
In the study of Van der Ploeg et al. (2017), the sensitivity and the speciﬁcity of both the Landolt-C measurement of VA and that of the Plusoptix
photoscreener were derived from the examinations at 45 and 60 months.
4
Acta Ophthalmologica 2019
performed in the same way in all areas
of Flanders.
The Plusoptix photoscreener was
introduced on request by Kind en Gezin
in2006. Since 2013, examinationwith the
Plusoptix photoscreener has been added
at the age of 1 and 2.5 years carried out
by a nurse in a CHCC in 330 health care
centres ofKind enGezin. The training of
thenurses is organized internallybyKind
en Gezin through online learning mod-
ules and practical training, which take
around 1 week. Measurement of VA at
age 3, 4 and 6 has a coverage between
95% and 100% (Guerin & Hoppen-
brouwers 2003), while measurement of
refractive error by the Plusoptix photo-
screener in children between 0 and
3 years had a participation of 80.4%
(59 595) in 2013. After detection of risk
factors of amblyopia, children are
referred to an ophthalmologist.
Outcomes of the vision screening at age
one
For this analysis, all children born in
2013 in Flanders were eligible. Follow-
ing screening by the Plusoptix, based on
the original AAPOS 2003 referral cri-
teria, in total 81% (56 759) children
participated in the vision screening at
age one, 90.8% (51 148) of these chil-
dren passed the test, and 9.2% (5187) of
the children were referred. In Table 2,
the number of tests, the reasons for
referral to an ophthalmologist and the
percentage of referrals for a speciﬁc
referral criterion are shown. Children
were sometimes tested more than once
and 5187 children were referred based
on more than 1 reason for referral.
Astigmatism was the most common
reason for referral. Of the children with
known follow-up results, 44.1% were
diagnosed by the ophthalmologist as
having a risk factor for amblyopia at
age one. Of these, 13% were treated
(Cijferrapport Oogscreening, Kind en
Gezin, unpublished, 2015).
In October 2013, the original
AAPOS 2003 referral criteria were
adjusted by CHCC Kind en Gezin,
because of the high referral rates in
2013. In Table 2, screening results of
children aged one born in 2014 in
Flanders are presented, based on the
adjusted referral criteria: astigma-
tism ≥ 3 dioptres, anisometropia ≥ 1.5
dioptres, hypermetropia ≥ 4 dioptres,
myopia ≥ 4 dioptres, anisoco-
ria > 1 mm. In total, 50 955 children
aged 1 participated in the vision screen-
ing in 2014. Following screening by the
Plusoptix 7.9% (4025) of the children
were referred, based on these revised
criteria (Boelaert et al. 2017). Of all
known follow-up results, 71% were
diagnosed to be at risk for amblyopia
at age one. In 50% of these children,
treatment was started, 0.9% of children
were treated with occlusion therapy,
3.7% with occlusion therapy and
glasses and 56% with glasses only
(Boelaert et al. 2017). Note that these
criteria are slightly diﬀerent from the
revised AAPOS 2013 referral criteria.
To put the 7.9% referral rate fol-
lowing from the screening by the Plu-
soptix photoscreener into perspective,
the regular vision screening at age 3
had 7.1% (11 771) referral and 2.3%
(3813) repeat examination, whereas for
vision screening between ages 4 and 6,
8.3% (19 345) was referred and 0.5%
(1165) needed re-examination (Guerin
2014, data from 2005 to 2008).
Field orientation in Iran
Since 1996, vision screening has been
introduced in all 31 provinces in Iran.
It started in the city of Bandar Abbas
as a pilot screening program for
kindergarten children. As of 2000, all
children in the cities and rural areas
were included (Raﬁei et al. 2017). All
provinces have directors who organize
yearly training sessions of 1–2 days for
kindergarten teachers and nurses. The
costs of training are supported by
Welfare Organizations which are paid
by the government. The standard
screening procedure is measurement
of visual acuity by the Snellen’s illiter-
ate E-chart at the ages of 3–6 years.
Children aged 3–6 years are screened
at least once (Raﬁei et al. 2017). This is
performed by certiﬁed kindergarten
teachers, child health care nurses, pri-
mary school teachers and other trained
professionals (Khandekar et al. 2009).
The Plusoptix photoscreener was
ﬁrst introduced in Iran in 2011 and
was subsequently implemented in all 31
provinces. Measurements are carried
out by optometrists and child health-
care nurses. However, Plusoptix pho-
toscreening is only used when
measurement of VA by the E-chart
fails, so photoscreening is not the
primary screening test. It is mostly
used for uncooperative children or
children with mental disorders. So,
while most children are screened for
low vision and amblyopia itself, some
children are screened for risk factors
instead.
In case of suspected vision problems
detected at the screening, children are
ﬁrst referred to optometrists. In case of
uncertainty in diagnosis or unsuccess-
ful treatment results, the child is
referred to the ophthalmologist (Khan-
dekar et al. 2009).
For this analysis, all children born in
2016 in Iran were included. Figure 1
gives an overview of the results of the
vision screening for children aged 3–6
in 2016. Participation in the vision
screening program was 90%, as at least
one screening test before entering
school is obligatory (Raﬁei et al.
2017). In total, 4 268 000 children were
screened in Iran in 2016, of which
1 622 939 (38%) children were
screened with the Plusoptix photo-
screener. It is unknown how many
children were referred based on the
Plusoptix photoscreener. Since there is
a higher percentage of children who
have been screened by the Plusoptix,
than initially was intended, it is possi-
ble that a transition is taking place
from using the Plusoptix when mea-
surement of VA failed or when children
Table 2. Reason for referral, after photoscreening at age one in Flanders.
Reason for referral Referrals (%, number) in 2013* Referrals (%) in 2014†
Astigmatism 49.20% (4433) 36.0%
Anisometropia 19.20% (1729) 14.3%
Hypermetropia 10.10% (906) 6.8%
Myopia 1.90% (169) 1.4%
Pupil diameter deviation 1.20% (107) 0.8%
Unknown 18.4% -
Other - 40.7%
* Reference: Report vision screening (Cijferrapport Oogscreening), Kind en Gezin, unpublished,
2015, Flanders, Belgium.
† Reference: Boelaert et al. (2017).
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were uncooperative to the use of the
Plusoptix as a primary screening tool.
Data collected from electronic screen-
ing records were supplied by the
national Welfare Organization in Teh-
ran, Iran.
Exploratory analysis of
the costs
In Flanders, approximately 100 000
tests are carried out every year. Costs
per test are between € 5.40 and 7.20
(the costs of the purchase and mainte-
nance of the Plusoptix photoscreener
device are not included). Each child
can be tested twice. Costs per child
were on average € 9.00. Between 2010
and 2013, 360 Plusoptix photoscreener
devices were purchased. Current costs
of the Plusoptix device are € 6.000-
8000, with a life span of approximately
4–7 years, after which the device will be
replaced (internal reporting Kind en
Gezin, unpublished, 2015). In Flan-
ders, in principle every device is
replaced after 4 years. Total costs of
the devices, covered by the government
were €630 000 annually in a population
of approximately 7.7 million. In the
observation period 2011–2016 in Flan-
ders, since the introduction of Plusop-
tix photoscreening, the number of
4-year-old children wearing glasses
has risen from 4.7% to 6.4% (Guerin
et al. 2017).
In Iran, the budget of the preventive
vision screening program is about
6 500 000 000 Iranian Toman
(€1 669 320) per year. The costs of the
ﬁrst screening were on average € 0.50
per child per screen. Costs of a consul-
tation with an optometrist were
€5.00. Costs of a consultation with
the ophthalmologist were €10.00. In
total, 260 Plusoptix devices were
employed in a population of approxi-
mately 80.2 million. Each device
costs  €7400. Plusoptix costs are paid
byWelfare organizations, which receive
government funding. There were no
maintenance costs of the Plusoptix
photoscreeners for the Welfare organi-
zations, as these are covered by the
Company Binamed that represents the
Plusoptix photoscreener in Iran.
Discussion
Worldwide, many diﬀerent screening
program strategies have been installed
to screen young children for amblyopia
in order to start treatment of ambly-
opia when the children are young. If
amblyopia is detected at age 7 or older,
it takes more time and it is more
diﬃcult to treat (Fronius et al. 2014).
This study shows two diﬀerent
approaches for the use of the Plusoptix
in a screening setting. In Flanders, it is
used primarily to prevent amblyopia by
detecting amblyopia risk factors at age
1 and 2.5 years of age in the whole
population, whereas in Iran it is used to
detect refractive errors or strabismus if
measurement of VA fails at age 3–6.
The way the Plusoptix photoscreener is
employed in Flanders and Iran diﬀers
fundamentally, leads to diﬀerent out-
comes and makes comparison diﬃcult.
The use of the Plusoptix photoscreener
between ages 3 and 6 in Iran, to
measure refractive error and possible
strabismus when VA measurement
fails, is an interesting alternative
option, to screen uncooperative, non-
verbal children, or children with mental
disorders who currently may not other-
wise be tested at all.
The Plusoptix photoscreener is used
exclusively without cycloplegia that is
common for determining refractive
errors by retinoscopy in young children
and therefore may under-detect hyper-
metropia, with a reported sensitivity of
33% (Paﬀ et al. 2010). Reports on its
detection of strabismus vary, with a
reported sensitivity of 25–41% (San-
chez et al. 2016). In the literature,
reports about the deployment of the
Plusoptix photoscreener and its eﬀec-
tiveness are diﬃcult to compare. It is
confusing that in some reports ambly-
opia and amblyopia risk factors are
presented as a single outcome measure.
As for children aged 4–6, it must be
realized that there is little use for
detecting risk factors for amblyopia at
an age that amblyopia itself can be
diagnosed by measurement of VA. The
use of the Plusoptix photoscreener as a
stand-alone screening test at ages 4–6
(Van der Ploeg et al. 2017) could be
considered unethical without addi-
tional measurement of VA, as approx-
imately one quarter of children with
amblyopia at that age do not have a
large refractive error or conspicuous
strabismus (Groenewoud et al. 2010)
and, hence, these children would not be
detected a priori if measurement of VA
would be replaced by photoscreening.
It is also confusing that the sensitivity
and speciﬁcity of photoscreeners for
detecting risk factors are calculated on
the basis of arbitrary thresholds for
referral, like the AAPOS criteria, as
children not fulﬁlling these criteria still
can have amblyopia. When the relation
between the size and type of the
refractive error or strabismus, and the
increased odds to develop amblyopia
will have been established in a large
study, the use of the AAPOS criteria
will no longer be necessary.
Refractive errors and strabismus are
known risk factors for amblyopia.
Hence, it is reasonable to believe that
4 268 000 children were 
screened in total in Iran 
in 2016
Of 75% of these 
children, information is 
known
3 212 000 children
8% was referred for 
second screen or 
optometrist 
259 353 children 
referred 
58.9% was examined by 
the optometrist after 
screening 
152 969 children 
examined
57.1% of the referrals 
(2.7% of total) were 
diagnosed with 
amblyopia and were 
treated
87 400 children 
diagnosed and treated
Fig. 1. Vision screening in Iran in 2016. Reference: Electronic screening records, Welfare
Organization, unpublished, 2016, Tehran, Iran.
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prescription of glasses at the age of one
does prevent some cases of amblyopia,
especially in children with strong
refractive errors. However, it is
unknown how many cases of ambly-
opia have been prevented by early
prescription of glasses in Flanders.
Data on beneﬁts of early prescription
of glasses have not been conﬁrmed with
published randomized controlled trials.
The evidence that early glasses prevent
the development of strabismus is still
quite weak. This would require a study
comparing two large cohorts, with
retinoscopy in all children at age one,
but prescription of glasses, in case of
amblyopia risk factors, in only one of
the two cohorts.
It is remarkable that in Flanders, a
new vision screening device has been
introduced in 2013 with considerable
costs, without secure evidence on how
many cases of amblyopia could be
prevented by early prescription of
glasses. The implementation of the
Plusoptix photoscreener to screen for
amblyopia risk factors in children aged
1 and 2.5 years costs €630 000 per year
for the devices alone, assuming the 360
Plusoptix devices for as many health-
care oﬃces, are used during 4 years.
The percentage of children wearing
glasses at age four has risen from
4.7% to 6.4% between 2011 and 2016
(Guerin et al. 2017) leading to
increased costs for parents.
In the VIP-HIP study by Group
et al. (2016) additional usefulness of
early prescription of glasses in
preschoolers was demonstrated, how-
ever. It was shown that high uncor-
rected hypermetropia in children was
associated with deﬁcits in early literacy
and essential skills. These deﬁcits lead
to problems in reading and writing
development. Children who experi-
enced reading problems in the ﬁrst
grade had an 88% chance of remaining
poor readers after ﬁnishing the fourth
grade and inﬂuencing later school per-
formances (Group et al. 2016).
Therefore, early detection of refrac-
tive errors might be useful for future
educational development of children. If
detection of risk factors by Plusoptix
photoscreener and prescription of early
glasses improves eﬃciency of educa-
tion, this would have a considerable
impact on its cost-beneﬁt analysis, but
only if refractive error is causal to the
educational disadvantage, not just
associated with it.
As of September 2018, the vision
screening program at Kind en Gezin in
Flanders has changed. The Plusoptix
devices have been replaced by a screen-
ing application on a smartphone with
moderate sensitivity and speciﬁcity for
the detection of amblyopia risk factors
(Guerin 2018).
Ethical approval
This article does not contain any stud-
ies with human participants or animals
performed by any of the authors.
Informed consent
Oral informed consent was obtained
from the participants interviewed in
this study.
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Appendix 1
Questionnaire on Vision
Screening Program in
Flanders.
1) Existing vision screening program
• How often are the children
screened in total and at what times?
• Is the vision screening in Flanders
performed in the same way in
diﬀerent regions? For example,
always by an orthoptist?
2) Addition of photoscreening
• At what age are the children
screened with the Plusoptix pho-
toscreener in Flanders?
• How many children are referred by
the Plusoptix photoscreener in
Flanders?
• What is the life expectancy of the
Plusoptix screening device in Flanders?
3) Implementation in vision
screening program
• Where does the vision screening
take place in Flanders?
• How are the children examined?
• Has the content of the vision
screening in Flanders changed over
the years, if so, what has changed,
and what have been the beneﬁts of
this?
4) Training
• What was the training organized
for screening professionals in
Flanders?
• Is a certiﬁcate required for training
for screening professionals? (is
there a periodic repetition of this
training)
• What are the costs of training for
screening professionals paid by the
government?
• By whom is the vision screening
performed?
• What are the salary costs of pro-
fessionals who perform vision
screening?
5) Attendance
• What is the percentage of children
invited for the vision screening in
Flanders?
• By whom are the children invited
for the vision screening in Flanders?
• How are the children invited for
the vision screening in Flanders?
• What is the percentage in the total
population participating in the
vision screening under the age of
7 years?
• Has the percentage of children
participating in the vision screen-
ing changed over the years, if so, is
it increased or decreased?
6) Diagnosis and treatment
• How long does a screening test
performed by the Plusoptix pho-
toscreener take place?
• How many children are referenced
annually in Flanders for further
diagnostics?
• What are the costs of referral
children after a positive test?
• What are the diﬀerences in the cost
of a consultation between an
orthoptist or an ophthalmologist?
• How many referred children are
treated annually?
• Has the number of prescription of
glasses increased since the intro-
duction of the Plusoptix?
7) Costs of vision screening
• How much money is spent per year
on preventive vision screening in
Flanders?
• What are the total screening costs
per child, per screen in Flanders?
• Are there diﬀerences in costs in the
diﬀerent regions in Flanders, with
regard to the vision screening?
• What are the purchase costs of the
Plusoptix screening devices in
Flanders?
• What are the maintenance costs of
the Plusoptix screening devices in
Flanders?
• Are there any other points that
you consider relevant in mapping
the cost-eﬀectiveness of the Plu-
soptix?
Appendix 2
Questionnaire on Vision
Screening Program in
Iran
1) Existing vision screening program
• How often are the children
screened in total and at what
times?
• Is the vision screening in Iran
performed in the same way in
diﬀerent regions? For example,
always by an optometrist?
2) Addition of photoscreening
• At what age are the children
screened with the Plusoptix pho-
toscreener in Iran?
• How many children are referred by
the Plusoptix photoscreener in
Iran?
• What is the life expectancy of the
Plusoptix screening device in Iran?
3) Implementation in vision
screening program
• Where does the vision screening
take place in Iran?
• How are the children examined?
• Has the content of the vision
screening in Iran changed over the
years, if so, what has changed, and
what have been the beneﬁts of this?
4) Training
• What was the training organized
for screening professionals in Iran?
• Is a certiﬁcate required for training
for screening professionals? (is
there a periodic repetition of this
training)
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• What are the costs of training for
screening professionals paid by the
government?
• By whom is the vision screening
performed?
• What are the salary costs of pro-
fessionals who perform vision
screening?
5) Attendance
• What is the percentage of children
invited for the vision screening in
Iran?
• By whom are the children
invited for the vision screening in
Iran?
• How are the children invited for
the vision screening in Iran?
• What is the percentage in the total
population participating in the
vision screening under the age of
7 years?
• Has the percentage of children
participating in the vision screen-
ing changed over the years, if so, is
it increased or decreased?
6) Diagnosis and treatment
• How long does a screening test
performed by the Plusoptix pho-
toscreener take place?
• How many children are referenced
annually in Iran for further diag-
nostics?
• What are the costs of referral
children after a positive test?
• What are the diﬀerences in the cost
of a consultation between an opto-
metrist or an ophthalmologist?
• How many referred children are
treated annually?
• Has the number of prescription of
glasses increased since the intro-
duction of the Plusoptix?
7) Costs of vision screening
• How much money is spent per year
on preventive vision screening in
Iran?
• What are the total screening costs
per child, per screen in Iran?
• Are there diﬀerences in costs in the
diﬀerent regions in Iran, with
regard to the vision screening?
• What are the purchase costs of the
Plusoptix screening devices in
Iran?
• What are the maintenance costs of
the Plusoptix in Iran?
• Are there any other points that
you consider relevant in mapping
the cost-eﬀectiveness of the Plu-
soptix?
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